RNU6-583P

Across TCGA pan-cancer cohorts, RNU6-583P RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated RNU6-583P data layer.

The strongest signal is observed in liver hepatocellular carcinoma (LIHC), where higher RNU6-583P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-583P expression acts as an unfavorable survival marker, although some lineages such as COAD and UCS show a favorable association.

LIHC, LUAD, and LGG are the cancer types where RNU6-583P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LIHC	OS	Tertile	All	0.671	0.800	.005	55	view →
LUAD	DFS	Quartile	III,IV	0.504	0.680	.013	45	view →
LGG	OS	Median	All	0.719	0.868	<.001	42	view →
CESC	DFS	Tertile	III,IV	0.535	0.858	.003	40	view →
KICH	DFS	Tertile	All	0.444	0.919	.003	26	view →
COAD	OS	Median	II,III,IV	0.782	0.470	.005	25	view →
UCS	DFS	Median	IV	0.952	0.367	.001	24	view →
BLCA	OS	Tertile	III,IV	0.710	0.559	.004	23	view →
CHOL	OS	Median	III,IV	0.286	1.000	.008	21	view →
KIRC	DFS	Tertile	All	0.551	0.696	.019	19	view →
SARC	DFS	Median	All	0.422	0.581	.002	19	view →
PCPG	DFS	Tertile	All	0.231	0.830	.008	18	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

RNU6-583P–LIHC (OS)

Open the LIHC breakdown →